Doctoral School in Medical and Health Sciences, Jagiellonian University Medical College, Kraków, Poland.
The Doctoral School of the Medical University of Silesia, Katowice, Poland.
Neurol Sci. 2024 Mar;45(3):1109-1119. doi: 10.1007/s10072-023-07129-5. Epub 2023 Oct 18.
With increasing life expectancy and the rising incidence of stroke in young adults, it is important to know the long-term prognosis of this condition. Post-stroke delirium and post-stroke dementia are common complications of stroke that negatively affect prognosis. The purpose of this study was to evaluate five-year mortality from stroke and to assess the influence of post-stroke delirium and post-stroke dementia on mortality and disability over the five-year period.
Consecutive patients admitted to the stroke unit for acute stroke or transient ischemic attacks were screened for in-hospital delirium. At the three- and twelve-month follow-up, the same patients underwent neurocognitive testing. Diagnoses of in-hospital delirium and dementia after three and twelve months based on DSM-5 criteria. Five years after stroke surviving patients were reevaluated. Outcome assessment included place of stay, current functional status assessed by the modified Rankin Scale (mRS), or death.
At the five-years of follow-up, data were collected from 575 of 750 patients originally included in the study (76.67%). The mortality rate was 51.65%. In-hospital post-stroke delirium and post-stroke dementia diagnosed three and twelve months after stroke were independent risk factors for death and an increase in mRS score of ≥ 1 or ≥ 2 points. There was no significant association with institutionalization rate.
More than half of post-stroke patients die within five years of follow-up. Post-stroke delirium and post-stroke dementia are associated with an increased risk of death and disability.
随着预期寿命的延长和年轻人中风发病率的上升,了解这种疾病的长期预后非常重要。中风后谵妄和中风后痴呆是中风的常见并发症,对预后产生负面影响。本研究的目的是评估中风后五年的死亡率,并评估中风后谵妄和中风后痴呆对五年期间死亡率和残疾的影响。
连续入组急性中风或短暂性脑缺血发作的中风单元患者进行住院期间谵妄筛查。在 3 个月和 12 个月的随访中,相同的患者接受神经认知测试。根据 DSM-5 标准在 3 个月和 12 个月后诊断住院期间谵妄和痴呆。中风后 5 年,对存活患者进行重新评估。结局评估包括居住地、改良 Rankin 量表(mRS)评估的当前功能状态或死亡。
在 5 年的随访中,从最初纳入研究的 750 名患者中收集了 575 名(76.67%)的数据。死亡率为 51.65%。住院期间的中风后谵妄和中风后痴呆在中风后 3 个月和 12 个月后诊断为死亡和 mRS 评分增加≥1 或≥2 分的独立危险因素。与机构化率无显著相关性。
超过一半的中风后患者在随访的五年内死亡。中风后谵妄和中风后痴呆与死亡和残疾风险增加相关。